XML 18 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Information for Subsidiary Guarantors and Non-guarantor Subsidiaries (Tables)
6 Months Ended
Dec. 31, 2012
Financial Information for Subsidiary Guarantors and Non Guarantor Subsidiaries [Abstract]  
Condensed Consolidating Balance Sheets
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Balance Sheets
June 30, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$

 
$

 
$
305.8

 
$
149.7

 
$

 
$
455.5

Restricted cash

 

 

 
0.8

 
1.6

 

 
2.4

Accounts receivable, net

 

 

 
570.8

 
131.3

 

 
702.1

Inventories

 

 

 
93.2

 
3.8

 

 
97.0

Prepaid expenses and other current assets
0.1

 

 

 
281.8

 
44.1

 

 
326.0

Total current assets
0.1

 

 

 
1,252.4

 
330.5

 

 
1,583.0

Property, plant and equipment, net

 

 

 
1,802.6

 
307.5

 

 
2,110.1

Goodwill

 

 

 
680.9

 
87.5

 

 
768.4

Intangible assets, net

 
49.0

 
0.3

 
27.0

 
12.7

 

 
89.0

Investments in consolidated subsidiaries
608.8

 

 

 

 

 
(608.8
)
 

Investments in securities

 

 

 

 
51.8

 

 
51.8

Intercompany receivable

 
1,674.2

 

 

 

 
(1,674.2
)
 

Other assets

 

 

 
65.3

 
120.5

 

 
185.8

Total assets
$
608.9

 
$
1,723.2

 
$
0.3

 
$
3,828.2

 
$
910.5

 
$
(2,283.0
)
 
$
4,788.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
 
 
 

Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
 

Accounts payable
$

 
$

 
$

 
$
316.8

 
$
73.8

 
$

 
$
390.6

Accrued expenses and other current liabilities
0.1

 
73.2

 

 
392.7

 
120.9

 

 
586.9

Current maturities of long-term debt

 
8.2

 

 
2.1

 
0.9

 

 
11.2

Total current liabilities
0.1

 
81.4

 

 
711.6

 
195.6

 

 
988.7

Other liabilities

 

 

 
547.6

 
201.8

 

 
749.4

Long-term debt, less current maturities

 
2,672.0

 
9.9

 
4.2

 
9.3

 

 
2,695.4

Intercompany payable
307.3

 

 
66.7

 
1,483.6

 
193.5

 
(2,051.1
)
 

Redeemable non-controlling interests

 

 

 

 
53.1

 

 
53.1

Total equity (deficit)
301.5

 
(1,030.2
)
 
(76.3
)
 
1,081.2

 
257.2

 
(231.9
)
 
301.5

Total liabilities and equity
$
608.9

 
$
1,723.2

 
$
0.3

 
$
3,828.2

 
$
910.5

 
$
(2,283.0
)
 
$
4,788.1


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Balance Sheets
December 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$

 
$

 
$
276.2

 
$
81.6

 
$

 
$
357.8

Restricted cash

 

 

 
4.1

 
1.6

 

 
5.7

Accounts receivable, net

 

 

 
562.5

 
103.9

 

 
666.4

Inventories

 

 

 
85.4

 
11.2

 

 
96.6

Prepaid expenses and other current assets

 

 

 
212.1

 
56.0

 

 
268.1

Total current assets

 

 

 
1,140.3

 
254.3

 

 
1,394.6

Property, plant and equipment, net

 

 

 
1,846.2

 
299.1

 

 
2,145.3

Goodwill

 

 

 
672.4

 
100.3

 

 
772.7

Intangible assets, net

 
45.0

 
0.3

 
31.5

 
11.0

 

 
87.8

Investments in consolidated subsidiaries
608.8

 

 

 

 

 
(608.8
)
 

Investments in securities

 

 

 

 
57.9

 

 
57.9

Intercompany receivable

 
1,573.3

 

 

 

 
(1,573.3
)
 

Other assets

 

 

 
73.5

 
106.6

 

 
180.1

Total assets
$
608.8

 
$
1,618.3

 
$
0.3

 
$
3,763.9

 
$
829.2

 
$
(2,182.1
)
 
$
4,638.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
 
 
 

Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
 

Accounts payable
$

 
$

 
$

 
$
309.2

 
$
59.9

 
$

 
$
369.1

Accrued expenses and other current liabilities
0.1

 
73.4

 

 
335.0

 
111.2

 

 
519.7

Current maturities of long-term debt

 
8.2

 

 
2.7

 
1.7

 

 
12.6

Total current liabilities
0.1

 
81.6

 

 
646.9

 
172.8

 

 
901.4

Other liabilities

 

 

 
501.9

 
156.8

 

 
658.7

Long-term debt, less current maturities

 
2,669.7

 
10.3

 
3.6

 
7.0

 

 
2,690.6

Intercompany payable
276.3

 

 
66.9

 
1,475.2

 
131.8

 
(1,950.2
)
 

Redeemable non-controlling interests

 

 

 

 
55.3

 

 
55.3

Total equity (deficit)
332.4

 
(1,133.0
)
 
(76.9
)
 
1,136.3

 
305.5

 
(231.9
)
 
332.4

Total liabilities and equity
$
608.8

 
$
1,618.3

 
$
0.3

 
$
3,763.9

 
$
829.2

 
$
(2,182.1
)
 
$
4,638.4

Condensed Consolidating Statements of Operations
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Operations
For the three months ended December 31, 2011
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
1,139.4

 
$
152.9

 
$
(5.7
)
 
$
1,286.6

Premium revenues

 

 

 
25.3

 
167.3

 
(3.8
)
 
188.8

Total revenues

 

 

 
1,164.7

 
320.2

 
(9.5
)
 
1,475.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
3.9

 

 

 
628.9

 
69.6

 

 
702.4

Health plan claims expense

 

 

 
5.8

 
147.2

 
(5.7
)
 
147.3

Supplies

 

 

 
202.9

 
25.0

 

 
227.9

Purchased services

 

 

 
111.7

 
21.7

 

 
133.4

Rents and leases

 

 

 
15.2

 
3.5

 

 
18.7

Other operating expenses

 

 

 
113.2

 
21.9

 
(3.8
)
 
131.3

Medicare and Medicaid EHR incentives

 

 

 
(21.3
)
 

 

 
(21.3
)
Depreciation and amortization

 

 

 
56.1

 
9.7

 

 
65.8

Interest, net

 
43.5

 
0.4

 
(4.8
)
 
4.1

 

 
43.2

Acquisition related expenses

 

 

 
0.2

 
0.2

 

 
0.4

Management fees

 

 

 
(7.2
)
 
7.2

 

 

Other

 

 

 
(1.4
)
 
(0.4
)
 

 
(1.8
)
Income (loss) from continuing operations before income taxes
(3.9
)
 
(43.5
)
 
(0.4
)
 
65.4

 
10.5

 

 
28.1

Income tax benefit (expense)
(11.3
)
 

 

 

 
4.3

 
(4.3
)
 
(11.3
)
Equity in earnings of subsidiaries
30.9

 

 

 

 

 
(30.9
)
 

Income (loss) from continuing operations
15.7

 
(43.5
)
 
(0.4
)
 
65.4

 
14.8

 
(35.2
)
 
16.8

Loss from discontinued operations, net of taxes

 

 

 
(0.3
)
 

 

 
(0.3
)
Net income (loss)
15.7

 
(43.5
)
 
(0.4
)
 
65.1

 
14.8

 
(35.2
)
 
16.5

Net income attributable to non-controlling interests

 

 

 

 
(0.8
)
 

 
(0.8
)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
15.7

 
$
(43.5
)
 
$
(0.4
)
 
$
65.1

 
$
14.0

 
$
(35.2
)
 
$
15.7

VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Operations
For the three months ended December 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
1,108.5

 
$
217.7

 
$
(6.4
)
 
$
1,319.8

Premium revenues

 

 

 
15.4

 
177.9

 

 
193.3

Total revenues

 

 

 
1,123.9

 
395.6

 
(6.4
)
 
1,513.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
2.7

 

 

 
552.6

 
142.8

 

 
698.1

Health plan claims expense

 

 

 
9.1

 
147.1

 
(6.4
)
 
149.8

Supplies

 

 

 
206.1

 
26.4

 

 
232.5

Purchased services

 

 

 
117.2

 
31.0

 

 
148.2

Rents and leases

 

 

 
13.8

 
5.0

 

 
18.8

Other operating expenses
0.1

 

 

 
118.9

 
26.1

 

 
145.1

Medicare and Medicaid EHR incentives

 

 

 
(14.4
)
 
(0.1
)
 

 
(14.5
)
Depreciation and amortization

 

 

 
57.2

 
10.6

 

 
67.8

Interest, net

 
51.4

 
0.3

 
(9.7
)
 
7.7

 

 
49.7

Acquisition related expenses

 

 

 
0.1

 

 

 
0.1

Management fees

 

 

 
(3.3
)
 
3.3

 

 

Other

 

 

 
(1.7
)
 
(0.1
)
 

 
(1.8
)
Income (loss) from continuing operations before income taxes
(2.8
)
 
(51.4
)
 
(0.3
)
 
78.0

 
(4.2
)
 

 
19.3

Income tax benefit (expense)
(7.2
)
 

 

 

 
(3.6
)
 
3.6

 
(7.2
)
Equity in earnings of subsidiaries
22.2

 

 

 

 

 
(22.2
)
 

Net income (loss)
12.2

 
(51.4
)
 
(0.3
)
 
78.0

 
(7.8
)
 
(18.6
)
 
12.1

Net loss attributable to non-controlling interests

 

 

 

 
0.1

 

 
0.1

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
12.2

 
$
(51.4
)
 
$
(0.3
)
 
$
78.0

 
$
(7.7
)
 
$
(18.6
)
 
$
12.2


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Operations
For the six months ended December 31, 2011
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
2,296.1

 
$
228.9

 
$
(13.1
)
 
$
2,511.9

Premium revenues

 

 

 
39.9

 
367.5

 
(7.6
)
 
399.8

Total revenues

 

 

 
2,336.0

 
596.4

 
(20.7
)
 
2,911.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
4.6

 

 

 
1,253.1

 
109.7

 

 
1,367.4

Health plan claims expense

 

 

 
16.3

 
308.8

 
(13.1
)
 
312.0

Supplies

 

 

 
403.7

 
37.8

 

 
441.5

Purchased services

 

 

 
226.5

 
33.9

 

 
260.4

Rents and leases

 

 

 
31.2

 
5.5

 

 
36.7

Other operating expenses
0.1

 

 

 
232.5

 
39.4

 
(7.6
)
 
264.4

Medicare and Medicaid EHR incentives

 

 

 
(24.4
)
 

 

 
(24.4
)
Depreciation and amortization

 

 

 
113.3

 
15.1

 

 
128.4

Interest, net

 
86.3

 
3.8

 
(7.6
)
 
6.5

 

 
89.0

Acquisition related expenses

 

 

 
8.0

 
4.6

 

 
12.6

Debt extinguishment costs

 

 
38.9

 

 

 

 
38.9

Management fees

 

 

 
(13.4
)
 
13.4

 

 

Other

 

 

 
(3.9
)
 
(0.3
)
 

 
(4.2
)
Income (loss) from continuing operations before income taxes
(4.7
)
 
(86.3
)
 
(42.7
)
 
100.7

 
22.0

 

 
(11.0
)
Income tax benefit (expense)
3.9

 

 

 

 
9.7

 
(9.7
)
 
3.9

Equity in earnings of subsidiaries
(5.2
)
 

 

 

 

 
5.2

 

Income (loss) from continuing operations
(6.0
)
 
(86.3
)
 
(42.7
)
 
100.7

 
31.7

 
(4.5
)
 
(7.1
)
Loss from discontinued operations, net of taxes

 

 

 
(0.4
)
 

 

 
(0.4
)
Net income (loss)
(6.0
)
 
(86.3
)
 
(42.7
)
 
100.3

 
31.7

 
(4.5
)
 
(7.5
)
Net loss attributable to non-controlling interests

 

 

 

 
1.5

 

 
1.5

Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
(6.0
)
 
$
(86.3
)
 
$
(42.7
)
 
$
100.3

 
$
33.2

 
$
(4.5
)
 
$
(6.0
)





VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Operations
For the six months ended December 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Patient service revenues, net
$

 
$

 
$

 
$
2,201.3

 
$
426.2

 
$
(13.4
)
 
$
2,614.1

Premium revenues

 

 

 
30.0

 
339.7

 

 
369.7

Total revenues

 

 

 
2,231.3

 
765.9

 
(13.4
)
 
2,983.8

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
4.9

 

 

 
1,089.6

 
283.8

 

 
1,378.3

Health plan claims expense

 

 

 
17.0

 
280.5

 
(13.4
)
 
284.1

Supplies

 

 

 
407.7

 
50.9

 

 
458.6

Purchased services

 

 

 
232.4

 
63.0

 

 
295.4

Rents and leases

 

 

 
28.0

 
9.8

 

 
37.8

Other operating expenses
0.2

 

 

 
237.1

 
52.0

 

 
289.3

Medicare and Medicaid EHR incentives

 

 

 
(20.4
)
 
(5.4
)
 

 
(25.8
)
Depreciation and amortization

 

 

 
112.4

 
21.0

 

 
133.4

Interest, net

 
102.8

 
0.6

 
(17.8
)
 
14.9

 

 
100.5

Acquisition related expenses

 

 

 
0.1

 

 

 
0.1

Management fees

 

 

 
(6.6
)
 
6.6

 

 

Other

 

 

 
(6.7
)
 
(0.2
)
 

 
(6.9
)
Income (loss) from continuing operations before income taxes
(5.1
)
 
(102.8
)
 
(0.6
)
 
158.5

 
(11.0
)
 

 
39.0

Income tax benefit (expense)
(12.1
)
 

 

 

 
(6.6
)
 
6.6

 
(12.1
)
Equity in earnings of subsidiaries
43.3

 

 

 

 

 
(43.3
)
 

Income (loss) from continuing operations
26.1

 
(102.8
)
 
(0.6
)
 
158.5

 
(17.6
)
 
(36.7
)
 
26.9

Income from discontinued operations, net of taxes

 

 

 
0.1

 

 

 
0.1

Net income (loss)
26.1

 
(102.8
)
 
(0.6
)
 
158.6

 
(17.6
)
 
(36.7
)
 
27.0

Net income attributable to non-controlling interests

 

 

 

 
(0.9
)
 

 
(0.9
)
Net income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
26.1

 
$
(102.8
)
 
$
(0.6
)
 
$
158.6

 
$
(18.5
)
 
$
(36.7
)
 
$
26.1

Condensed Statements of Comprehensive Income (Loss)
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Comprehensive Income (Loss)
For the three months ended December 31, 2011
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
15.7

 
$
(43.5
)
 
$
(0.4
)
 
$
65.1

 
$
14.8

 
$
(35.2
)
 
$
16.5

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding gains on investments in securities, net

 

 

 

 
1.4

 

 
1.4

Other comprehensive income before taxes

 

 

 

 
1.4

 

 
1.4

Change in income tax expense

 

 

 

 
(0.5
)
 

 
(0.5
)
Other comprehensive income, net of taxes

 

 

 

 
0.9

 

 
0.9

Comprehensive income (loss)
15.7

 
(43.5
)
 
(0.4
)
 
65.1

 
15.7

 
(35.2
)
 
17.4

Net income attributable to non-controlling interests

 

 

 

 
(0.8
)
 

 
(0.8
)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
15.7

 
$
(43.5
)
 
$
(0.4
)
 
$
65.1

 
$
14.9

 
$
(35.2
)
 
$
16.6


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Comprehensive Income (Loss)
For the three months ended December 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
12.2

 
$
(51.4
)
 
$
(0.3
)
 
$
78.0

 
$
(7.8
)
 
$
(18.6
)
 
$
12.1

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding gains on investments in securities, net

 

 

 

 
1.1

 

 
1.1

Other comprehensive income before taxes

 

 

 

 
1.1

 

 
1.1

Change in income tax expense

 

 

 

 
(0.4
)
 

 
(0.4
)
Other comprehensive income, net of taxes

 

 

 

 
0.7

 

 
0.7

Comprehensive income (loss)
12.2

 
(51.4
)
 
(0.3
)
 
78.0

 
(7.1
)
 
(18.6
)
 
12.8

Net loss attributable to non-controlling interests

 

 

 

 
0.1

 

 
0.1

Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
12.2

 
$
(51.4
)
 
$
(0.3
)
 
$
78.0

 
$
(7.0
)
 
$
(18.6
)
 
$
12.9


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Comprehensive Income (Loss)
For the six months ended December 31, 2011

 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
(6.0
)
 
$
(86.3
)
 
$
(42.7
)
 
$
100.3

 
$
31.7

 
$
(4.5
)
 
$
(7.5
)
Other comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding losses on investments in securities, net

 

 

 

 
(1.8
)
 

 
(1.8
)
Other comprehensive loss before taxes

 

 

 

 
(1.8
)
 

 
(1.8
)
Change in income tax benefit

 

 

 

 
0.9

 

 
0.9

Other comprehensive loss, net of taxes

 

 

 

 
(0.9
)
 

 
(0.9
)
Comprehensive income (loss)
(6.0
)
 
(86.3
)
 
(42.7
)
 
100.3

 
30.8

 
(4.5
)
 
(8.4
)
Net loss attributable to non-controlling interests

 

 

 

 
1.5

 

 
1.5

Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
(6.0
)
 
$
(86.3
)
 
$
(42.7
)
 
$
100.3

 
$
32.3

 
$
(4.5
)
 
$
(6.9
)

VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Comprehensive Income (Loss)
For the six months ended December 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Net income (loss)
$
26.1

 
$
(102.8
)
 
$
(0.6
)
 
$
158.6

 
$
(17.6
)
 
$
(36.7
)
 
$
27.0

Other comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized holding gains on investments in securities, net

 

 

 

 
3.3

 

 
3.3

Other comprehensive income before taxes

 

 

 

 
3.3

 

 
3.3

Change in income tax expense

 

 

 

 
(1.4
)
 

 
(1.4
)
Other comprehensive income, net of taxes

 

 

 

 
1.9

 

 
1.9

Comprehensive income (loss)
26.1

 
(102.8
)
 
(0.6
)
 
158.6

 
(15.7
)
 
(36.7
)
 
28.9

Net income attributable to non-controlling interests

 

 

 

 
(0.9
)
 

 
(0.9
)
Comprehensive income (loss) attributable to Vanguard Health Systems, Inc. stockholders
$
26.1

 
$
(102.8
)
 
$
(0.6
)
 
$
158.6

 
$
(16.6
)
 
$
(36.7
)
 
$
28.0

Condensed Consolidating Statements of Cash Flows
VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Cash Flows
For the six months ended December 31, 2011
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
(6.0
)
 
$
(86.3
)
 
$
(42.7
)
 
$
100.3

 
$
31.7

 
$
(4.5
)
 
$
(7.5
)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss from discontinued operations, net of taxes

 

 

 
0.4

 

 

 
0.4

Depreciation and amortization

 

 

 
113.3

 
15.1

 

 
128.4

Amortization of loan costs

 
3.2

 

 

 

 

 
3.2

Accretion of principal on notes

 
1.4

 
3.8

 

 

 

 
5.2

Acquisition related expenses

 

 

 
8.0

 
4.6

 

 
12.6

Stock compensation
4.6

 

 

 

 

 

 
4.6

Deferred income taxes
(5.9
)
 

 

 

 

 

 
(5.9
)
Debt extinguishment costs

 

 
38.9

 

 

 

 
38.9

Other

 

 

 
(1.1
)
 

 

 
(1.1
)
Changes in operating assets and liabilities net of the impact of acquisitions
7.3

 
10.6

 

 
(167.7
)
 
(15.4
)
 
(7.0
)
 
(172.2
)
Net cash provided by (used in) operating activities — continuing operations

 
(71.1
)
 

 
53.2

 
36.0

 
(11.5
)
 
6.6

Net cash used in operating activities — discontinued operations

 

 

 
(0.4
)
 

 

 
(0.4
)
Net cash provided by (used in) operating activities
$

 
$
(71.1
)
 
$

 
$
52.8

 
$
36.0

 
$
(11.5
)
 
$
6.2


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Cash Flows
For the six months ended December 31, 2011
(Continued)
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisitions and related expenses, net of cash acquired
$

 
$

 
$

 
$
(209.9
)
 
$
1.1

 
$

 
$
(208.8
)
Capital expenditures

 

 

 
(132.0
)
 
(5.2
)
 

 
(137.2
)
Net proceeds from sales of investments in securities

 

 

 
1.9

 
10.0

 

 
11.9

Other investing activities

 

 

 
2.3

 
(3.0
)
 

 
(0.7
)
Net cash provided by (used in) investing activities

 

 

 
(337.7
)
 
2.9

 

 
(334.8
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financing activities:
 
 
 
 
 
 
 
 
 
 
 
 

Payments of long-term debt and capital lease obligations

 
(8.2
)
 
(445.8
)
 
(6.6
)
 
(0.1
)
 

 
(460.7
)
Proceeds from issuance of common stock
67.5

 

 

 

 

 

 
67.5

Payments of IPO related costs
(6.9
)
 

 

 

 

 

 
(6.9
)
Payment of tender premiums on note redemption

 

 
(27.6
)
 

 

 

 
(27.6
)
Cash provided by (used in) intercompany activity
(60.2
)
 
79.3

 
473.4

 
(301.2
)
 
(201.0
)
 
9.7

 

Other financing activities
(0.4
)
 

 

 

 
(3.0
)
 
1.8

 
(1.6
)
Net cash provided by (used in) financing activities

 
71.1

 

 
(307.8
)
 
(204.1
)
 
11.5

 
(429.3
)
Net decrease in cash and cash equivalents

 

 

 
(592.7
)
 
(165.2
)
 

 
(757.9
)
Cash and cash equivalents, beginning of period

 

 

 
644.1

 
292.5

 

 
936.6

Cash and cash equivalents, end of period
$

 
$

 
$

 
$
51.4

 
$
127.3

 
$

 
$
178.7


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Cash Flows
For the six months ended December 31, 2012
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
$
26.1

 
$
(102.8
)
 
$
(0.6
)
 
$
158.6

 
$
(17.6
)
 
$
(36.7
)
 
$
27.0

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Income from discontinued operations, net of taxes

 

 

 
(0.1
)
 

 

 
(0.1
)
Depreciation and amortization

 

 

 
112.4

 
21.0

 

 
133.4

Amortization of loan costs

 
4.4

 

 

 

 

 
4.4

Accretion of principal on senior discount notes

 
1.7

 
0.5

 

 

 

 
2.2

Acquisition related expenses

 

 

 
0.1

 

 

 
0.1

Stock compensation
4.9

 

 

 

 

 

 
4.9

Deferred income taxes
7.0

 

 

 

 

 

 
7.0

Other

 

 

 
1.2

 

 

 
1.2

Changes in operating assets and liabilities, net of impact of acquisitions
(38.0
)
 
0.1

 

 
(52.3
)
 
(46.0
)
 
43.3

 
(92.9
)
Net cash provided by (used in) operating activities — continuing operations

 
(96.6
)
 
(0.1
)
 
219.9

 
(42.6
)
 
6.6

 
87.2

Net cash provided by operating activities — discontinued operations

 

 

 
0.1

 

 

 
0.1

Net cash provided by (used in) operating activities
$

 
$
(96.6
)
 
$
(0.1
)
 
$
220.0

 
$
(42.6
)
 
$
6.6

 
$
87.3


VANGUARD HEALTH SYSTEMS, INC.
Condensed Consolidating Statements of Cash Flows
For the six months ended December 31, 2012
(Continued)
 
Parent
 
Issuers of
Senior
Notes and
Term Debt
 
Issuers of
Senior
Discount
Notes
 
Guarantor
Subsidiaries
 
Combined
Non-
Guarantors
 
Eliminations
 
Total
Consolidated
 
(In millions)
Investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisitions and related expenses, net of cash acquired
$

 
$

 
$

 
$
(6.9
)
 
$
(0.3
)
 
$

 
$
(7.2
)
Capital expenditures

 

 

 
(178.4
)
 
(8.8
)
 

 
(187.2
)
Net purchases of investments in securities

 

 

 

 
(3.0
)
 

 
(3.0
)
Net reimbursements from restricted cash and escrow fund

 

 

 
17.8

 

 

 
17.8

Other investing activities

 

 

 
1.3

 

 

 
1.3

Net cash used in investing activities

 

 

 
(166.2
)
 
(12.1
)
 

 
(178.3
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financing activities:
 
 
 
 
 
 
 
 
 
 
 
 

Payments of long-term debt and capital lease obligations

 
(4.1
)
 

 
0.1

 
(1.5
)
 

 
(5.5
)
Other financing activities
(1.2
)
 
(0.2
)
 

 

 
0.2

 

 
(1.2
)
Cash provided by (used in) intercompany activity
1.2

 
100.9

 
0.1

 
(83.5
)
 
(12.1
)
 
(6.6
)
 

Net cash provided by (used in) financing activities

 
96.6

 
0.1

 
(83.4
)
 
(13.4
)
 
(6.6
)
 
(6.7
)
Net decrease in cash and cash equivalents

 

 

 
(29.6
)
 
(68.1
)
 

 
(97.7
)
Cash and cash equivalents, beginning of period

 

 

 
305.8

 
149.7

 

 
455.5

Cash and cash equivalents, end of period
$

 
$

 
$

 
$
276.2

 
$
81.6

 
$

 
$
357.8